NEW YORK--(BUSINESS WIRE)--
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Amyris, Inc. (AMRS) resulting from allegations that Amyris may have issued materially misleading business information to the investing public.
On April 17, 2017, Amyris disclosed revenues of $67.2 million for fiscal year 2016, representing a decrease of $10 million from the revenue figures it disclosed on March 2, 2017 and April 3, 2017. The decrease in revenue was due to Amyris’ decision in the first quarter of 2017 to take an equity stake in one of Blue California’s affiliates that focused on the sweetener market in lieu of cash payment under the license agreement. On this news, shares of Amyris fell $0.10 per share or over 14.69% to close at $0.60 per share on April 18, 2017.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Amyris investors. If you purchased shares of Amyris on or before April 17, 2017, please visit the firm’s website at http://www.rosenlegal.com/cases-1104.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.